Electrochemical Behaviours of Scutellarin at Multi-Wall Carbon Nanotubes Modified Glassy Carbon Electrode

Article Preview

Abstract:

A multi-wall carbon nanotube modified glassy carbon electrode (MWCNTs/GCE) has been prepared. The electrochemical behavior of scutellarin at the modified electrode and its electroanalytical method have been studied. It was showed that in 0.20 mol/L Na2HPO4-NaH2PO4 buffer solution (pH=7.4) MWCNTs/GCE exhibited excellent catalytic and enhancement effect on the electrochemical oxidation of scutellarin, the sensitivity increaced 23 times compared with that at bare GCE. The measurement parameters were optimized. Under the optimal conditions, the linear range of scutellarin concentration was 4.0×10-6-1.0×10-4 mol/L (R=0.9991) with a detection limit of 8.2×10-7 mol/L(S/N =3), and the RSD for 4.0×10-5 mol/L scutellarin solution was 1.8% (n=11). This method was successfully used in the determination of scutellarin in injection and tablets.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 602-604)

Pages:

239-242

Citation:

Online since:

December 2012

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] X. Lin, K.D. Chu: Strait Pharm. J., 2005, 17, 5 (in Chinese).

Google Scholar

[2] X.L. Zhang, S.H. Liu, F. Zhou: Sichuan J.Physiol. Sci., 2008, 30,75 (in Chinese).

Google Scholar

[3] J.M. Cui, S. Wu: Nat.Produ.Res.Dev., 2003, 15, 255 (in Chinese).

Google Scholar

[4] X. Q. Shi, Y.M. Chen, Y. Wang, N. Li: J. Hebei Med Col. Conti. Edu., 2008, 25, 80 (in Chinese).

Google Scholar

[5] X.D. Zhang, J. Liu, W.B. Zhang, L. Liu : China Pharm., 2007, 16, 3(in Chinese).

Google Scholar

[6] S.Y. Yang, X.H. Zhong, Y.Z. Zhang: J. Jilin Med. Col., 2008, 29, 360 (in Chinese).

Google Scholar

[7] P. He, W.G. Tian, S.W. Wang: Modern Med. Health 2006, 22, 2291(in Chinese).

Google Scholar

[8] X. E. Jiang: Med.Theo. Prac., 2009, 22, 915(in Chinese).

Google Scholar

[9] L. Ma, B.H. Zhu, J.W. Chen, Q.Y. Qiu, J.G. Zhou, Y.Y. Guan: Chin. Pharm. Bul., 2004, 20, 1030 (in Chinese).

Google Scholar

[10] L. Wang, Y.H. Xiao, Q. Hu, Z.Q. Pan: Chem. Bioeng., 2007, 24, 9 (in Chinese).

Google Scholar

[11] N.Wei: China Pharm., 2001, 4, 144 (in Chinese).

Google Scholar

[12] D.H. Xie: New Med., 2007, 38, 408 (in Chinese).

Google Scholar

[13] Y.F. Wang, Y. Zhang, G.Z. Hao: J. Disease. Moni. Contr., 2010, 4, 138 (in Chinese).

Google Scholar

[14] Drug Specifications Promulgated by the Ministry of Public Health, P R China. Chinese Traditional Patent Formulation Preparation. Vol 20, 1998. 105 (in Chinese).

Google Scholar

[15] N.X. Liang, H. Yu, L.J. Zhang, Y.D. Guo: J.Yunnan Uni.,2006, 28,150 (in Chinese).

Google Scholar

[16] J. M. Wang, J. W. Wang, Q.W. Li, Z.G. Chen, P. X. Cai, J.Y. Mo: Chin. Tradit. Herb. Drug.,2008, 39, 375 (in Chinese).

Google Scholar

[17] J. F. Zheng, W. L. Li, F. Feng: Chin. J. Pharm. Anal., 2011, 31, 34. (in Chinese).

Google Scholar